115 related articles for article (PubMed ID: 2580141)
1. A comparison of the cardiotonic effects of AR-L115 and AR-L57: evidence for distinct inotropic mechanisms.
Hayes JS; Wyss VL; Wilson H; Pollock GD
J Cardiovasc Pharmacol; 1985; 7(1):182-9. PubMed ID: 2580141
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF
J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955
[TBL] [Abstract][Full Text] [Related]
3. Effects of AR-L 115 on contraction and relaxation of isolated mammalian cardiac muscle.
Brutsaert DL; De Clerck NM; Housmans PR; Van Ocken ER
J Cardiovasc Pharmacol; 1982; 4(3):333-43. PubMed ID: 6177927
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
Hayes JS; Bowling N; Boder GB; Kauffman R
J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
[TBL] [Abstract][Full Text] [Related]
6. Contractility and protein phosphorylation in cardiomyocytes: effects of isoproterenol and AR-L57.
Hayes JS; Bowling N; Boder GB
Am J Physiol; 1984 Aug; 247(2 Pt 2):H157-69. PubMed ID: 6087683
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure.
Pouleur H; Rousseau MF; van Mechelen H; Roncoroni L; Ries A; Charlier AA
J Cardiovasc Pharmacol; 1982; 4(3):409-18. PubMed ID: 6177937
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action.
Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
J Cardiovasc Pharmacol; 1987 Apr; 9(4):425-34. PubMed ID: 2438505
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of the positive inotropic effect of piroximone in cat papillary muscle.
Cheng HC; Kariya T; Gleason EM; Dage RC
J Cardiovasc Pharmacol; 1985; 7(4):747-52. PubMed ID: 2410717
[TBL] [Abstract][Full Text] [Related]
10. Investigations of the mechanism of the positive inotropic action of BDF 9148: comparison with DPI 201-106 and the enantiomers.
Raap A; Armah B; Mest HJ; Stenzel W; Schloos J; Blechacz W
J Cardiovasc Pharmacol; 1997 Feb; 29(2):164-73. PubMed ID: 9057064
[TBL] [Abstract][Full Text] [Related]
11. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
Brown L; Erdmann E
Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
[TBL] [Abstract][Full Text] [Related]
13. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
[TBL] [Abstract][Full Text] [Related]
14. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
Collis MG; Keddie JR; Rouse W
Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
[TBL] [Abstract][Full Text] [Related]
15. Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326).
Hayes JS; Bowling N; Pollock GD; Robertson DW
J Pharmacol Exp Ther; 1986 Apr; 237(1):18-24. PubMed ID: 3007737
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug.
Diederen W; Weisenberger H
Arzneimittelforschung; 1981; 31(1a):177-82. PubMed ID: 7195215
[No Abstract] [Full Text] [Related]
17. Activation of muscarinic receptors elicits inotropic responses in ventricular muscle from rats with heart failure through myosin light chain phosphorylation.
Hussain RI; Qvigstad E; Birkeland JA; Eikemo H; Glende A; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Krobert KA
Br J Pharmacol; 2009 Feb; 156(4):575-86. PubMed ID: 19159405
[TBL] [Abstract][Full Text] [Related]
18. Comparative positive inotropic effects of TA-064 (denopamine), a new cardiotonic agent, and isoproterenol and ouabain on guinea pig ventricular muscles.
Sato T; Imanishi S; Arita M
J Cardiovasc Pharmacol; 1989 Oct; 14(4):519-25. PubMed ID: 2478764
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one).
Roebel LE; Dage RC; Cheng HC; Woodward JK
J Cardiovasc Pharmacol; 1982; 4(5):721-9. PubMed ID: 6182401
[TBL] [Abstract][Full Text] [Related]
20. Evidence that prazosin disturbs isoprenaline positive inotropic action in the guinea pig heart papillary muscle.
Kocić I
Pol J Pharmacol; 1996; 48(4):447-52. PubMed ID: 9112686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
